Last reviewed · How we verify
NCT04296201
Evaluation of the Immediate Effect and Safety of DMA™ Novel Muscle Stimulation Technology
NA trial testing DMA treatment in Skin Laxity in 15 participants. Completed in 15 February 2021.
15 February 2021
Quick facts
| Lead sponsor | Lumenis Be Ltd. |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 15 |
| Start date | 1 September 2020 |
| Primary completion | 15 February 2021 |
| Estimated completion | 15 February 2021 |
| Sites | 1 location across United States |
Drugs / interventions tested
- DMA treatment
Conditions studied
- Skin Laxity — all drugs for Skin Laxity →
- Muscle Contracture — all drugs for Muscle Contracture →
Sponsor
Lumenis Be Ltd. — full company profile →
Who can join
Adults 25 to 45, any sex, with Skin Laxity or Muscle Contracture. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
A total of at least 15 and up to 17 healthy subjects at a single site, aged 25-45 years old, who wish to receive a lifting effect and improved muscle definition, will be included in the study. The procedure will include treatments with the Legend Pro™ DMA™ technology. Photos will be obtained at pre-defined time points throughout the study.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04296201
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Skin Laxity
Currently open trials in the same condition.
- NCT07224880 — Ellacor® Micro-Coring Technology® in Fitzpatrick Skin Types I-VI, Including Patients Receiving Glucagon-Like Peptide-1 R · recruiting
- NCT06941610 — An Evaluation of the Erchonia Laser As a Non-Invasive Treatment to Improve the Appearance of Skin Laxity · NA · recruiting
- NCT06724510 — Safety and Efficacy Evaluation of High Intensity Focused Ultrasound Device in Eyebrow Lifting · NA · recruiting
- NCT06603194 — Benefit of Bovine or Marine Collagen Vs. Placebo on Skin, Hair, Nails and Whole Body Health in Healthy Adults · NA · recruiting
- NCT06557434 — AV-23-001 AVAVA MIRIA Pilot Study · NA · active not recruiting
Other Lumenis Be Ltd. trials
Trials by the same sponsor.
- NCT07039461 — Evaluation of Effectiveness and Safety of Intense Pulsed Light Treatment for Chalazion · NA · terminated
- NCT06885112 — Clinical Study to Evaluate the Improvement in Hair Loss in Skin of Color Treated With Fractional Non-Ablative Laser · NA · recruiting
- NCT05945069 — Feasibility of Dynamic Muscle Stimulation + Radiofrequency for Improving Blink Quality in Subjects with Dry Eye Disease · NA · completed
- NCT05957029 — Evaluation of Thermal Outcome and Safety of Nuera Tight RF System · NA · completed
- NCT05773924 — Evaluation of Efficacy and Safety of the triLift™ System · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04296201 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Lumenis Be Ltd.
- Last refreshed: 17 February 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04296201.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing